TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.120
-0.010 (-0.88%)
Jun 5, 2025, 10:32 AM - Market open

TherapeuticsMD Statistics

Total Valuation

TherapeuticsMD has a market cap or net worth of $12.96 million. The enterprise value is $14.31 million.

Market Cap 12.96M
Enterprise Value 14.31M

Important Dates

The last earnings date was Tuesday, May 13, 2025, after market close.

Earnings Date May 13, 2025
Ex-Dividend Date n/a

Share Statistics

TherapeuticsMD has 11.57 million shares outstanding. The number of shares has increased by 5.99% in one year.

Current Share Class 11.57M
Shares Outstanding 11.57M
Shares Change (YoY) +5.99%
Shares Change (QoQ) +0.17%
Owned by Insiders (%) 1.61%
Owned by Institutions (%) 13.11%
Float 9.56M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 7.08
Forward PS n/a
PB Ratio 0.49
P/TBV Ratio 0.58
P/FCF Ratio 9.30
P/OCF Ratio 9.30
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 7.77
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 10.17

Financial Position

The company has a current ratio of 2.64, with a Debt / Equity ratio of 0.26.

Current Ratio 2.64
Quick Ratio 1.84
Debt / Equity 0.26
Debt / EBITDA n/a
Debt / FCF 4.95
Interest Coverage -1,566.50

Financial Efficiency

Return on equity (ROE) is -7.72% and return on invested capital (ROIC) is -5.58%.

Return on Equity (ROE) -7.72%
Return on Assets (ROA) -4.88%
Return on Invested Capital (ROIC) -5.58%
Return on Capital Employed (ROCE) -9.35%
Revenue Per Employee $1.84M
Profits Per Employee -$2.10M
Employee Count 1
Asset Turnover 0.05
Inventory Turnover n/a

Taxes

Income Tax -63,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -48.87% in the last 52 weeks. The beta is 0.64, so TherapeuticsMD's price volatility has been lower than the market average.

Beta (5Y) 0.64
52-Week Price Change -48.87%
50-Day Moving Average 1.21
200-Day Moving Average 1.30
Relative Strength Index (RSI) 35.93
Average Volume (20 Days) 54,264

Short Selling Information

The latest short interest is 90,601, so 0.78% of the outstanding shares have been sold short.

Short Interest 90,601
Short Previous Month 118,076
Short % of Shares Out 0.78%
Short % of Float 0.95%
Short Ratio (days to cover) 1.95

Income Statement

In the last 12 months, TherapeuticsMD had revenue of $1.84 million and -$2.10 million in losses. Loss per share was -$0.19.

Revenue 1.84M
Gross Profit 1.84M
Operating Income -3.13M
Pretax Income -6.13M
Net Income -2.10M
EBITDA -2.66M
EBIT -3.13M
Loss Per Share -$0.19
Full Income Statement

Balance Sheet

The company has $5.75 million in cash and $6.97 million in debt, giving a net cash position of -$1.23 million or -$0.11 per share.

Cash & Cash Equivalents 5.75M
Total Debt 6.97M
Net Cash -1.23M
Net Cash Per Share -$0.11
Equity (Book Value) 26.74M
Book Value Per Share 2.31
Working Capital 7.77M
Full Balance Sheet

Cash Flow

Operating Cash Flow 1.41M
Capital Expenditures n/a
Free Cash Flow 1.41M
FCF Per Share $0.12
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -170.18% and -114.07%.

Gross Margin 100.00%
Operating Margin -170.18%
Pretax Margin -119.61%
Profit Margin -114.07%
EBITDA Margin -144.60%
EBIT Margin -170.18%
FCF Margin 76.43%

Dividends & Yields

TherapeuticsMD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -5.99%
Shareholder Yield -5.99%
Earnings Yield -16.06%
FCF Yield 10.76%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on May 9, 2022. It was a reverse split with a ratio of 0.02:1.

Last Split Date May 9, 2022
Split Type Reverse
Split Ratio 0.02:1

Scores

TherapeuticsMD has an Altman Z-Score of -33.92 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -33.92
Piotroski F-Score 4